NYSE:BMEBlackrock Health Sciences Trust Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Blackrock Health Sciences Trust Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $42.90 -0.20 (-0.46 %) (As of 06/4/2020 01:39 PM ET) Add Compare Share Today's Range$42.57Now: $42.90▼$43.1050-Day Range$37.60MA: $40.62▼$43.0052-Week Range$27.00Now: $42.90▼$43.99Volume4,673 shsAverage Volume55,129 shsMarket CapitalizationN/AP/E RatioN/ADividend Yield0.06%BetaN/A ProfileAdvanced ChartCompetitorsDividendFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services. It also invests through equity derivatives, with an emphasis on option writing. The fund benchmarks the performance of its portfolio against the Russell 3000 Healthcare Index. BlackRock Health Sciences Trust was formed on March 31, 2005 and is domiciled in the United States.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Blackrock Health Sciences Trust. Previous Next 2.4 Community Rank Outperform VotesBlackrock Health Sciences Trust has received 157 “outperform” votes. (Add your “outperform” vote.)Underperform VotesBlackrock Health Sciences Trust has received 167 “underperform” votes. (Add your “underperform” vote.)Community SentimentBlackrock Health Sciences Trust has received 51.54% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Blackrock Health Sciences Trust and other stocks. Vote “Outperform” if you believe BME will outperform the S&P 500 over the long term. Vote “Underperform” if you believe BME will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 1.7 Dividend Strength Dividend LeadershipBlackrock Health Sciences Trust is a leading dividend payer. It pays a dividend yield of 0.06%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthBlackrock Health Sciences Trust does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Blackrock Health Sciences Trust insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.81 out of 5 stars Industry, Sector and Symbol Stock Exchange NYSE Industry Closed-End Fund - Equity Sub-IndustryN/A SectorFinance Current SymbolNYSE:BME Previous Symbol CUSIPN/A CIK1314966 Webwww2.blackrock.com Phone+1-800-8820052Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable BME Rates by TradingView Receive BME News and Ratings via Email Sign-up to receive the latest news and ratings for BME and its competitors with MarketBeat's FREE daily newsletter. Blackrock Health Sciences Trust (NYSE:BME) Frequently Asked Questions How has Blackrock Health Sciences Trust's stock been impacted by COVID-19 (Coronavirus)? Blackrock Health Sciences Trust's stock was trading at $37.25 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, BME stock has increased by 15.2% and is now trading at $42.90. View which stocks have been most impacted by Coronavirus. How often does Blackrock Health Sciences Trust pay dividends? What is the dividend yield for Blackrock Health Sciences Trust? Blackrock Health Sciences Trust declared a monthly dividend on Monday, June 1st. Investors of record on Monday, June 15th will be paid a dividend of $0.20 per share on Tuesday, June 30th. This represents a $2.40 annualized dividend and a yield of 5.59%. The ex-dividend date is Friday, June 12th. View Blackrock Health Sciences Trust's dividend history. Has Blackrock Health Sciences Trust been receiving favorable news coverage? News coverage about BME stock has trended somewhat negative this week, according to InfoTrie. The research group identifies negative and positive news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Blackrock Health Sciences Trust earned a media sentiment score of -1.0 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the company's share price in the near future. View the latest news aboutBlackrock Health Sciences Trust. Who are some of Blackrock Health Sciences Trust's key competitors? Some companies that are related to Blackrock Health Sciences Trust include Advantex Marketing International (ADX), Calamos Global Dynamic Income Fund (CHW), Cohen & Steers Quality Income Realty (RQI), Macquarie/First Trust Global Infrstrctre (MFD), Nuveen Tax-Advantaged Ttl Rtrn Strtgy Fd (JTA), Reaves Utility Income Fund (UTG) and The Gabelli Dividend & Income Trust (GDV). View all competitors. What other stocks do shareholders of Blackrock Health Sciences Trust own? Based on aggregate information from My MarketBeat watchlists, some companies that other Blackrock Health Sciences Trust investors own include AbbVie (ABBV), Gilead Sciences (GILD), IBM (IBM), Exxon Mobil (XOM), Enterprise Products Partners (EPD), Verizon Communications (VZ), AT&T (T), Alibaba Group (BABA), Johnson & Johnson (JNJ) and Energy Transfer LP Unit (ET). Who are Blackrock Health Sciences Trust's key executives? Blackrock Health Sciences Trust's management team includes the following people: Mr. John M. Perlowski, Chief Exec. Officer and Pres (Age 55)Mr. Neal J. Andrews, Chief Financial Officer (Age 53)Mr. Charles Choon Sik Park, Chief Compliance Officer and Anti-Money Laundering Officer (Age 52)Mr. Michael D. Carey CFA, Managing Director and Portfolio Mang.Mr. Jay M. Fife, Treasurer (Age 49) What is Blackrock Health Sciences Trust's stock symbol? Blackrock Health Sciences Trust trades on the New York Stock Exchange (NYSE) under the ticker symbol "BME." Who are Blackrock Health Sciences Trust's major shareholders? Blackrock Health Sciences Trust's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Morgan Stanley (0.00%), Morgan Stanley (0.00%), Invesco Ltd. (0.00%), UBS Group AG (0.00%), Raymond James Financial Services Advisors Inc. (0.00%) and Cambridge Investment Research Advisors Inc. (0.00%). View institutional ownership trends for Blackrock Health Sciences Trust. Which institutional investors are selling Blackrock Health Sciences Trust stock? BME stock was sold by a variety of institutional investors in the last quarter, including HighTower Advisors LLC, Cetera Advisor Networks LLC, Jacobi Capital Management LLC, and Rikoon Group LLC. View insider buying and selling activity for Blackrock Health Sciences Trust. Which institutional investors are buying Blackrock Health Sciences Trust stock? BME stock was acquired by a variety of institutional investors in the last quarter, including Morgan Stanley, Morgan Stanley, Advisor Group Holdings Inc., UBS Group AG, Invesco Ltd., Centaurus Financial Inc., Mid Atlantic Financial Management Inc. ADV, and Commonwealth Equity Services LLC. View insider buying and selling activity for Blackrock Health Sciences Trust. How do I buy shares of Blackrock Health Sciences Trust? Shares of BME can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Blackrock Health Sciences Trust's stock price today? One share of BME stock can currently be purchased for approximately $42.90. What is Blackrock Health Sciences Trust's official website? The official website for Blackrock Health Sciences Trust is www2.blackrock.com. How can I contact Blackrock Health Sciences Trust? Blackrock Health Sciences Trust's mailing address is 100 Bellevue Pkwy, WILMINGTON, DE 19809-3700, United States. The company can be reached via phone at +1-800-8820052. This page was last updated on 6/4/2020 by MarketBeat.com Staff
